NYSE:ENOVMedical Equipment
Enovis (ENOV) Is Up 16.3% After Reaffirming 2026 Outlook And Narrowing Losses – Has The Bull Case Changed?
Enovis Corporation recently reported first-quarter 2026 results, with sales rising to US$589.15 million from US$558.83 million a year earlier and net loss narrowing to US$8.76 million from US$55.97 million, while basic and diluted loss per share from continuing operations improved to US$0.15 from US$0.98.
The company also reaffirmed its full-year 2026 revenue guidance of about US$2.31 billion to US$2.37 billion, highlighting confidence in growth from its Reconstructive segment and new...